Skip to content
healthcare.dev

GURUNANDA NASAL SALINE

NDC 70708-110, NASAL WASH, powder, for solution, from GURUNANDA LLC.

Product NDC
70708-110
Status
Listed
Labeler
GURUNANDA LLC
Dosage form
POWDER, FOR SOLUTION
Route
NASAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70708-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM BICARBONATE.515 g/2.2g
  • SODIUM CHLORIDE1.685 g/2.2g

Pharmacologic classes

Alkalinizing Activity [MoA]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Package NDCNDC-11Package
70708-110-1270708011012120 PACKET in 1 BOX (70708-110-12) / 2.2 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 70708-110 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70708-110 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70708-110. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.